Corcept Therapeutics Incorporated (CORT) vs Summit Therapeutics PLC (SMMT)
- Corcept Therapeutics Incorporated CORT 110.16 −2.83%
- Summit Therapeutics PLC SMMT 14.63 −4.81%
Corcept Therapeutics Incorporated and Summit Therapeutics PLC are both Biotechnology companies. Corcept Therapeutics Incorporated and Summit Therapeutics PLC are of similar size ($12.3B and $12.3B). Summit Therapeutics PLC has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 212×. Corcept Therapeutics Incorporated grew revenue faster over the last twelve months: 16.0% against −61.0%. Corcept Therapeutics Incorporated has the higher net margin (6.53% vs 0.00%) and the higher return on invested capital (1.01% vs 0.00%). Across the 18 metrics below, Corcept Therapeutics Incorporated leads on 15 and Summit Therapeutics PLC on 3.
Valuation
Profitability
| Metric | CORT | SMMT | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.30% | 100.00% | 65.16% |
| Operating margin | 0.77% | 0.00% | 0.00% |
| Net margin | 6.53% | 0.00% | 0.00% |
| Free cash flow margin | 12.87% | 0.00% | 0.00% |
| Return on equity | 8.08% | (192.50%) | (56.36%) |
| Return on assets | 6.41% | (159.09%) | (48.04%) |
| Return on invested capital | 1.01% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack